Atlas Trials

Predictive Biomarkers for Response to Nivolumab in Head and Neck Squamous Cell Carcinoma

Clinical trial NCT03652142 · UNKNOWN

Trial details

NCT number
NCT03652142
Sponsor
Attikon Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
HNSCCDNA DamageDNA Double Strand Break
Start date
2018-05-01
Primary completion
2020-05-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.